This may be simply attributed to the expression levels of RocA targets (eIF4A1, eIF4A2 and DDX3X), which are much higher in hematological cancer tissues than in normal tissues (data not shown). Here, DDX3X is linked to hematopoietic and lymphoid cell neoplasm.